X
Biopeak
Connect: •••
•••• ••••
•••
Key Metrics of Biopeak
  • Market Cap
  • Total Equity Funding ₹95 Cr in 5 rounds
  • Latest Funding Round ₹27 Cr, Series A Dec 05, 2025
  • Post Money Valuation ₹290 Cr as on Dec 05, 2025
  • Annual Revenue ₹39.8 Lakh
    as on Mar 31, 2025
  • EBITDA -₹7.2 Cr
    as on Mar 31, 2025
  • EBITDA Margin -1,812.25%
    as on Mar 31, 2025
  • Net Profit ₹5.4 Cr (Loss)
    as on Mar 31, 2025
  • Net Profit Margin -1,365.91%
    as on Mar 31, 2025
About the Company

Provider of personalized health programs integrating diagnostics and multidisciplinary expertise. The organization delivers advanced diagnostic services, personalized protocols, and multidisciplinary...

Loading...
Price on BSE Volume

Funding Rounds

Total Rounds: 5 Biopeak

S.No. Date Round Name Amount TTM Revenue Investors & Facilitators
1. Dec 5, 2025 Series A ₹27 Cr ₹39.8 Lakh
Inst: NK Squared
Angel: Nikhil, Rohan
2. Oct 16, 2025 Series A ₹7.7 Cr ₹39.8 Lakh
Inst: Saral Group
Angel: Gaurav
3. Jul 25, 2025 Series A ₹30 Cr ₹39.8 Lakh
Inst: Claypond Capital
Angel: Prashanth, Nikhil, Nitin
4. May 29, 2025 Seed ₹10.0 Cr ₹39.8 Lakh
Inst: Manipal Group
5. Aug 1, 2024 Angel ₹20 Cr -
Angel: Nikhil, Prashanth

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25
Detailed Income StatementFY 24-25 (in Cr)
0.4
7.6
Total profit before prior period items, exceptional items, extraordinary items and tax (7.2)
Exceptional items before tax 0
Total profit before extraordinary items and tax (7.2)
Extraordinary items before tax 0
Total profit before tax (7.2)
(1.8)
Total profit (loss) for period from continuing operations (5.4)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (5.4)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items 0
Basic earning per equity share (0.0)
Diluted earnings per equity share 0
Detailed Balance SheetFY 24-25 (in Cr)
12.8
12.8
Detailed Cash Flow StatementFY 24-25 (in Cr)

Shareholding Pattern

As of Dec 5, 2025 • Biopeak

Total Shares 0.47M

Top Shareholders

Shareholder Category Shares (Mn) % Holding
Prashanth Prakash Angel 0.18M 37.88%
Rishi Pardal Founder 0.15M 31.74%
Nikhil Kamath Angel 0.09M 18.19%
Claypond Capital Partners Private Limited Fund 0.02M 4.35%
Shiva Subramanian Founder 0.02M 3.85%
Others

    Top Competitors

    Similar companies to Biopeak

    Digbi Health

    digbihealth.com

    Genique

    genique.co

    Vibrant Wellness

    vibrant-wellness.com

    Miltel

    mirtel.co.jp

    expressTEC

    expresstec.pt

    Suisse Life Science

    suisselifescience.com
    No recent news
    Need help? Chat with us! WhatsApp